Health ❯ Healthcare ❯ Clinical Trials ❯ Efficacy Studies

Phase 3 Trials

FDA Approves Twice-Yearly Lenacapavir Injection for HIV Prevention

High list prices threaten to limit uptake under looming Medicaid cuts alongside HIV prevention budget reductions

FDA Approves Moderna’s mNEXSPIKE for High-Risk Populations